Description of Event or Problem · 1
A PHASE I CLINICAL TRIAL TO EVALUATE IMMUNE RESPONSE KINETICS AND SAFETY OF TWO DIFFERENT PRIMES: ADENOVIRAL VECTOR VACCINE AND DNA VACCINE; EACH FOLLOWED BY ADENOVIRAL BOOST IN HEALTHY, HIV-1 UNINFECTED ADULTS. THIS VACCINE IS GIVEN VIA IM INJECTION TO A NORMAL VOLUNTEER'S DELTOID USING A NEEDLE-FREE INJECTION SYSTEM PRODUCED BY BIOJECTOR. DURING A ROUTINE INJECTION AND AT THE TIME THE TRIGGER WAS PULLED, THE BIOJECTOR "KICKED-BACK" BREAKING THE SEAL BETWEEN THE ARM AND THE SYRINGE. RESULT: 1. AN INCOMPLETE INJECTION WAS GIVEN. SOME VACCINE ENTERED THE VOLUNTEER AND SOME VACCINE APPEARED ON THE SURFACE OF THE ARM (USING GAUZE SPONGE VACCINE WAS COLLECTED AND PLACED IN A YELLOW BIOHAZARD BAG).2. AT THE INJECTION SITE, A ONE CENTIMETER LONG, SUPERFICIAL LACERATION RESULTED FROM THE EXTERNAL STREAM OF VACCINE (AN OVAL DOT BANDAGE WAS APPLIED).